Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108) - Image 1

£113.76

Springer Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)

Name: Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)
Brand: Springer
Price: 113.76 GBP
Availability: InStock

Oncology

This is the most expensive it has ever been. Walk away.

£114 today · previous high £114 · all-time low £113

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days • 81 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £114 (48 days, 59.3%)

Price range: £113 - £114

Price levels: 2 different prices over 81 days

Description

Myelodysplastic syndromes are to the bone marrow what pneumonia is to the lungs; the response of an organ to a variety of etiologic insults like aging, toxic exposure, infections and auto-immunity. Among infectious causes alone, pneumonia could be the result of a variety of possible pathogens including bacterial, viral, tuberculous or fungal agents. Similarly, MDS cannot be treated as a single disease. Attempts to harness the inherent complexity of MDS by devising `classifications' which group the various syndromes as one disease is as misguided as saying that a pneumonia is not infectious because it did not respond to antibiotics. Progress in the field will occur faster when we re-analyze this premise. Therefore, until a clearer picture of the disease emerges it is best to treat each of the MDS syndromes as a separate entity. Having no classification is better than a misleading one. Cancer research has been notable for its periodic cycles of promise and hope, followed by defeat and disappointments. It is not that there is no solution, but that the problem has not been identified precisely. This book is our attempt to define the most crucial questions related to MDS that need to be addressed immediately through logic, analysis and rigorous experimentation. If the emerging problems appear daunting, then instead of being overwhelmed by them, we should follow the advice of the great 20th century thinker Antonio Gramsci, `pessimism of the intellect must be faced with the optimism of will'.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 1461355664
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Publication Date: 23 October 2012
Listed Since: 20 September 2013

Barcode

No barcode data available

Springer Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)

The Myelodysplastic Syndromes

Diagnosis of Blood and Bone Marrow Disorders

Diagnosis of Blood and Bone Marrow Disorders

Multiple Myeloma: Diagnosis and Treatment

Chronic Myeloproliferative Disorders

Multiple Myeloma - a New Era of Treatment Strategies

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

HIV-associated Hematological Malignancies

Aplastic Anemia and Other Bone Marrow Failure Syndromes

Handbook of Leukemia

Non-Neoplastic Hematologic Disorders: A Quick Review of Modern Diagnostic and Therapeutic Approaches

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Molecular Basis of Chronic Myeloproliferative Disorders

HIV & HTLV-I Associated Malignancies: 104 (Cancer Treatment and Research, 104)

Human Leukemias: Cytochemical and Ultrastructural Techniques in Diagnosis and Research: 14 (Developments in Oncology, 14)

Soft Tissue Sarcomas: New Developments in the Multidisciplinary Approach to Treatment: 56 (Cancer Treatment and Research, 56)

Childhood Acute Lymphoblastic Leukemia

Molecular Targeted Therapy of Lung Cancer

DNA Repair of Cancer Stem Cells

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Chronic Myeloid Leukemia (Hematologic Malignancies)

Unclassifiable Leukemias: Proceedings of a Symposium, held on October 11 - 13, 1974 at the Institute of Cell Pathology, Hopital de Bicetre, Paris, France.